Bonnie Clothier, Ph.D., R.N. is the new associate director of payor relations at Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA). According to the firm, Clothier will be responsible for providing internal and customer support to help identify specific payor issues and develop plans for gaining or improving U.S. coverage with health plans for new and innovative technologies.
Bonnie Clothier: New Associate Director at MCRA

Clothier most recently worked for Independence Blue Cross where she was responsible for reviewing and updating medical policy coverage positions, providing clinical rationale for appropriateness of medical billing codes, and analyzing utilization patterns of claims data.
Tim Hunter, MCRA’s Vice President of Health Economics, Reimbursement, and Public Policy said, “MCRA has a long history of working with payors to help them understand the important role and benefits of innovative medical devices and their associated procedures. We are excited that Bonnie has joined our Payor Relations team; with her combination of clinical and commercial insurance experience she will expand our ability to provide patient access to appropriate medical care.”
Dr. Clothier told OTW, “This new role provides a pathway to apply and, more importantly, blend experiences gathered as a clinician, researcher and third-party payor policy analyst. These combined experiences result from practicing as an advanced practice nurse, directing research activities in academia and the pharmaceutical industry, reviewing medical policy coverage positions and analyzing utilization patterns in claims data.”
“In addition to working with colleagues who are experts in their respective fields, I most look forward to assisting our clients, and ultimately the patients for whom the therapies are intended to benefit, obtain covered access to care that is evidenced- and value- based.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.